QRG Capital Management Inc. Raises Stock Position in Sabra Healthcare REIT, Inc. $SBRA

QRG Capital Management Inc. raised its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 8.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 66,212 shares of the real estate investment trust’s stock after acquiring an additional 5,416 shares during the period. QRG Capital Management Inc.’s holdings in Sabra Healthcare REIT were worth $1,221,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in SBRA. SVB Wealth LLC purchased a new stake in Sabra Healthcare REIT during the 1st quarter worth approximately $34,000. UMB Bank n.a. boosted its stake in Sabra Healthcare REIT by 379.6% during the 1st quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust’s stock worth $36,000 after purchasing an additional 1,621 shares during the period. Wealth Preservation Advisors LLC acquired a new stake in Sabra Healthcare REIT during the 1st quarter worth $38,000. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Sabra Healthcare REIT by 61.2% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 2,806 shares of the real estate investment trust’s stock worth $49,000 after acquiring an additional 1,065 shares during the period. Finally, Anchor Investment Management LLC acquired a new stake in shares of Sabra Healthcare REIT in the 1st quarter worth $58,000. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Stock Performance

Shares of SBRA opened at $17.98 on Thursday. Sabra Healthcare REIT, Inc. has a 52-week low of $15.60 and a 52-week high of $20.03. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. The firm has a 50-day moving average price of $18.77 and a 200 day moving average price of $18.16. The firm has a market capitalization of $4.31 billion, a PE ratio of 23.66, a P/E/G ratio of 1.21 and a beta of 0.85.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The company had revenue of $189.15 million during the quarter, compared to analyst estimates of $185.64 million. During the same quarter last year, the firm posted $0.36 EPS. The business’s revenue for the quarter was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, sell-side analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Friday, August 15th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 6.7%. Sabra Healthcare REIT’s dividend payout ratio is currently 157.89%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on SBRA. Wells Fargo & Company increased their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a report on Wednesday, August 27th. Cantor Fitzgerald initiated coverage on shares of Sabra Healthcare REIT in a research report on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 target price on the stock. Scotiabank lifted their price target on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a “sector perform” rating in a research report on Monday, June 23rd. Weiss Ratings reiterated a “buy (b)” rating on shares of Sabra Healthcare REIT in a research note on Wednesday. Finally, BMO Capital Markets upped their price target on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a “market perform” rating in a report on Monday, August 25th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $20.71.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.